The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human study of JSKN016, a bispecific anti-TROP2/HER3 antibody drug conjugate (ADC): Antitumor activity in patients (pts) with metastatic triple-negative breast cancer (mTNBC) and safety results.
 
Herui Yao
No Relationships to Disclose
 
Jieqiong Liu
No Relationships to Disclose
 
Yinduo Zeng
No Relationships to Disclose
 
Zhangzhou Huang
No Relationships to Disclose
 
Jing Wang
No Relationships to Disclose
 
Yu Cao
No Relationships to Disclose
 
Ying Wang
No Relationships to Disclose
 
Wenjing Wu
No Relationships to Disclose
 
Ya-Ping Yang
No Relationships to Disclose
 
Fengyan Yu
No Relationships to Disclose
 
Xiuping Lai
No Relationships to Disclose
 
Hong Zong
No Relationships to Disclose
 
Dongqing Lv
No Relationships to Disclose
 
Junyan Wu
No Relationships to Disclose
 
Suiwen Ye
No Relationships to Disclose
 
Ting Xu
Employment - Alphamab
Leadership - Alphamab
Stock and Other Ownership Interests - Alphamab
 
Zhenjiu Wang
Employment - Alphamab
 
Xiaowen Tang
Employment - Alphamab
 
Erwei Song
No Relationships to Disclose